Neuroprotective effect of bexarotene in the SOD1G93A mouse model of amyotrophic lateral sclerosis

Frontiers in Cellular Neuroscience

Volumn 9, Issue JULY, 2015, Pages

  Riancho, Javier ^a   Ruiz Soto, María ^b   Berciano, María T ^b   Berciano, José ^a   Lafarga, Miguel ^b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Amyotrophic lateral sclerosis; Bexarotene; G93ASOD1; Mouse; Proteostasis; Retinoid X receptor

Indexed keywords

BEXAROTENE; CATHEPSIN D; RETINOID X RECEPTOR ALPHA;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; GENE EXPRESSION; GENE SEQUENCE; HISTOLOGY; IMMUNOREACTIVITY; MALE; MOUSE; NERVE CELL DEGENERATION; NEUROMUSCULAR FUNCTION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ROTAROD TEST; SURVIVAL; TRANSGENIC MOUSE; WESTERN BLOTTING;

EID: 84936931216     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00250     Document Type: Article

References (98)

1. Adamec, E., Mohan, P. S., Cataldo, A. M., Vonsattel, J. P., and Nixon, R. A. (2000). Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease. Neuroscience 100, 663-675. doi:10.1016/S0306-4522(00)00281-5
2. An, T., Shi, P., Duan, W., Zhang, S., Yuan, P., Li, Z., et al. (2014). Oxidative stress and autophagic alteration in brainstem of SOD1-G93A mouse model of ALS. Mol. Neurobiol. 49(3):1435-48 doi:10.1007/s12035-013-8623-3
3. Andersen, P. M., and Al Chalabi, A. (2011). Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat. Rev. Neurol. 7, 603-615. doi:10.1038/nrneurol.2011.150
4. Anguiano, J., Garner, T. P., Mahalingam, M., Das, B. C., Gavathiotis, E., and Cuervo, A. M. (2013). Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives. Nat. Chem. Biol. 9, 374-382. doi:10.1038/nchembio.1230
5. Belanger, M., and Magistretti, P. J. (2009). The role of astroglia in neuroprotection. Dialogues. Clin. Neurosci. 11, 281-295.
6. Bendotti, C., Calvaresi, N., Chiveri, L., Prelle, A., Moggio, M., Braga, M., et al. (2001). Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J. Neurol. Sci. 191, 25-33. doi:10.1016/S0022-510X(01)00627-X
7. Bendotti, C., Marino, M., Cheroni, C., Fontana, E., Crippa, V., Poletti, A., et al. (2012). Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyo­trophic lateral sclerosis: implication for protein aggregation and immune response. Prog. Neurobiol. 97, 101-126. doi:10.1016/j.pneurobio.2011.10.001
8. Berciano, M. T., Novell, M., Villagra, N. T., Casafont, I., Bengoechea, R., Val-Bernal, J. F., et al. (2007). Cajal body number and nucleolar size correlate with the cell body mass in human sensory ganglia neurons. J. Struct. Biol. 158, 410-420. doi:10.1016/j.jsb.2006.12.008
9. Boisvert, F. M., van Koningsbruggen, S., Navascues, J., and Lamond, A. I. (2007). The multifunctional nucleolus. Nat. Rev. Mol. Cell Biol. 8, 574-585. doi:10.1038/nrm2184
10. Bosco, D. A., Morfini, G., Karabacak, N. M., Song, Y., Gros-Louis, F., Pasinelli, P., et al. (2010). Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 13, 1396-1403. doi:10.1038/nn.2660
11. Boya, P., and Kroemer, G. (2008). Lysosomal membrane permeabilization in cell death. Oncogene 27, 6434-6451. doi:10.1038/onc.2008.310
12. Brotherton, T. E., Li, Y., Cooper, D., Gearing, M., Julien, J. P., Rothstein, J. D., et al. (2012). Localization of a toxic form of superoxide dismutase 1 protein to patholog­ically affected tissues in familial ALS. Proc. Natl. Acad. Sci. U.S.A. 109, 5505-5510. doi:10.1073/pnas.1115009109
13. Casafont, I., Navascues, J., Pena, E., Lafarga, M., and Berciano, M. T. (2006). Nuclear organization and dynamics of transcription sites in rat sensory ganglia neurons detected by incorporation of 5'-fluorouridine into nascent RNA. Neuroscience 140, 453-462. doi:10.1016/j.neuroscience.2006.02.030
14. Casas, C., Herrando-Grabulosa, M., Manzano, R., Mancuso, R., Osta, R., and Navarro, X. (2013). Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis. Brain Behav. 3, 145-158. doi:10.1002/brb3.104
15. Cataldo, A. M., Barnett, J. L., Berman, S. A., Li, J., Quarless, S., Bursztajn, S., et al. (1995). Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14, 671-680. doi:10.1016/0896-6273(95)90324-0
16. Cheah, B. C., Vucic, S., Krishnan, A. V., and Kiernan, M. C. (2010). Riluzole, neuro­protection and amyotrophic lateral sclerosis. Curr. Med. Chem. 17, 1942-1199. doi:10.2174/092986710791163939
17. Cheng, B., Martinez, A. A., Morado, J., Scofield, V., Roberts, J. L., and Maffi, S. K. (2013). Retinoic acid protects against proteasome inhibition associated cell death in SH-SY5Y cells via the AKT pathway. Neurochem. Int. 62, 31-42. doi:10.1016/j.neuint.2012.10.014
18. Chiu, A. Y., Zhai, P., Dal Canto, M. C., Peters, T. M., Kwon, Y. W., Prattis, S. M., et al. (1995). Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell Neurosci. 6, 349-362. doi:10.1006/mcne.1995.1027
19. Corcoran, J., So, P. L., and Maden, M. (2002). Absence of retinoids can induce moto­neuron disease in the adult rat and a retinoid defect is present in motoneuron disease patients. J. Cell Sci. 115, 4735-4741. doi:10.1242/jcs.00169
20. Corona, J. C., Romo, L. B., and Tapia, R. (2007). Glutamate excitotoxicity and ther­apeutic targets for amyotrophic lateral sclerosis. Expert. Opin. Ther. Targets. 11, 1415-1428. doi:10.1517/14728222.11.11.1415
21. Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y., Karlo, J. C., Zinn, A. E., et al. (2012). ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335, 1503-1506. doi:10.1126/science.1217697
22. Crochemore, C., Virgili, M., Bonamassa, B., Canistro, D., Pena-Altamira, E., Paolini, M., et al. (2009). Long-term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model for amyotrophic lateral sclerosis. Muscle Nerve 39, 548-552. doi:10.1002/mus.21260
23. Crockett, S., Clarke, M., Reeves, S., and Sims, B. (2011). Cystine glutamate exchanger upregulation by retinoic acid induces neuroprotection in neural stem cells. Neuroreport 22, 598-602. doi:10.1097/WNR.0b013e3283494359
24. Delgado-Calle, J., Arozamena, J., Garcia-Renedo, R., Garcia-Ibarbia, C., Pascual-Carra, M. A., Gonzalez-Macias, J., et al. (2011). Osteocyte deficiency in hip fractures. Calcif. Tissue Int. 89, 327-334. doi:10.1007/s00223-011-9522-0
25. Duvic, M., Hymes, K., Heald, P., Breneman, D., Martin, A. G., Myskowski, P., et al. (2001a). Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J. Clin. Oncol. 19, 2456-2471.
26. Duvic, M., Martin, A. G., Kim, Y., Olsen, E., Wood, G. S., Crowley, C. A., et al. (2001b). Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch. Dermatol. 137, 581-593. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-137-5-dst0039
27. Evans, R. M., and Mangelsdorf, D. J. (2014). Nuclear receptors, RXR, and the big bang.Cell 157, 255-266. doi:10.1016/j.cell.2014.03.012
28. Farol, L. T., and Hymes, K. B. (2004). Bexarotene: a clinical review. Expert. Rev. Anticancer Ther. 4, 180-188. doi:10.1586/14737140.4.2.180
29. Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., and Shaw, P. J. (2011). Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 7, 616-630. doi:10.1038/nrneurol.2011.152
30. Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M., Castellano-Sanchez, A., et al. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185, 232-240. doi:10.1016/j.expneurol.2003.10.004
31. Fitz, N. F., Cronican, A. A., Lefterov, I., and Koldamova, R. (2013). Comment on “ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models”. Science 340, 924c-992c. doi:10.1126/science.1235809
32. Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., et al. (2014). Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog. Neurobiol. 112, 24-49. doi:10.1016/j.pneurobio.2013.10.004
33. Gurney, M. E., Fleck, T. J., Himes, C. S., and Hall, E. D. (1998). Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis. Neurology 50, 62-66. doi:10.1212/WNL.50.1.62
34. Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., et al. (1994). Motor neuron degeneration in mice that express a human Cu,Zn super­oxide dismutase mutation. Science 264, 1772-1775. doi:10.1126/science.8209258
35. Haidet-Phillips, A. M., Hester, M. E., Miranda, C. J., Meyer, K., Braun, L., Frakes, A., et al. (2011). Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 29, 824-828. doi:10.1038/nbt.1957
36. Hall, E. D., Oostveen, J. A., and Gurney, M. E. (1998). Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23, 249-256. doi:10.1002/ (SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#
37. Hetman, M., and Pietrzak, M. (2012). Emerging roles of the neuronal nucleolus. Trends Neurosci. 35, 305-314. doi:10.1016/j.tins.2012.01.002
38. Hetz, C., and Mollereau, B. (2014). Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci. 15, 233-249. doi:10.1038/nrn3689
39. Jaarsma, D., Haasdijk, E. D., Grashorn, J. A., Hawkins, R., van Duijn, W., Verspaget, H. W., et al. (2000). Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol. Dis. 7, 623-643. doi:10.1006/nbdi.2000.0299
40. Jokic, N., Ling, Y. Y., Ward, R. E., Michael-Titus, A. T., Priestley, J. V., and Malaspina, A. (2007). Retinoid receptors in chronic degeneration of the spinal cord: observations in a rat model of amyotrophic lateral sclerosis. J. Neurochem. 103, 1821-1833. doi:10.1111/j.1471-4159.2007.04893.x
41. Kikuchi, H., Almer, G., Yamashita, S., Guegan, C., Nagai, M., Xu, Z., et al. (2006). Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc. Natl. Acad. Sci. U.S.A. 103, 6025-6030. doi:10.1073/pnas.0509227103
42. Kinderman, N. B., and Jones, K. J. (1993). Testosterone enhancement of the nerve cell body response to injury: evidence using in situ hybridization and ribosomal DNA probes. J. Neurosci. 13, 1523-1532.
43. Kolarcik, C. L., and Bowser, R. (2012). Retinoid signaling alterations in amyotrophic lateral sclerosis. Am. J. Neurodegener. Dis. 1, 130-145.
44. Korac, J., Schaeffer, V., Kovacevic, I., Clement, A. M., Jungblut, B., Behl, C., et al. (2013). Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J. Cell Sci. 126, 580-592. doi:10.1242/jcs.114926
45. Koval, E. D., Shaner, C., Zhang, P., du Maine, X., Fischer, K., Tay, J., et al. (2013). Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum. Mol. Genet. 22, 4127-4135. doi:10.1093/hmg/ddt261
46. Kunst, C. B. (2004). Complex genetics of amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75, 933-947. doi:10.1086/426001
47. Lamond, A. I., and Spector, D. L. (2003). Nuclear speckles: a model for nuclear organelles. Nat. Rev. Mol. Cell Biol. 4, 605-612. doi:10.1038/nrm1172
48. Lane, M. A., and Bailey, S. J. (2005). Role of retinoid signalling in the adult brain. Prog. Neurobiol. 75, 275-293. doi:10.1016/j.pneurobio.2005.03.002
49. Lemmens, R., Moore, M. J., Al Chalabi, A., Brown, R. H. Jr., and Robberecht, W. (2010). RNA metabolism and the pathogenesis of motor neuron diseases. Trends Neurosci. 33, 249-258. doi:10.1016/j.tins.2010.02.003
50. Maden, M. (2007). Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat. Rev. Neurosci. 8, 755-765. doi:10.1038/nrn2212
51. Majounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., et al. (2012). Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 11, 323-330. doi:10.1016/S1474-4422(12)70043-1
52. Malaspina, A., Kaushik, N., and de Belleroche, J. (2001). Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J. Neurochem. 77, 132-145. doi:10.1046/j.1471-4159.2001.00231.x
53. Malaspina, A., and Turkheimer, F. (2007). A review of the functional role and of the expression profile of retinoid signaling and of nuclear receptors in human spinal cord. Brain Res. Bull. 71, 437-446. doi:10.1016/j.brainresbull.2006.10.032
54. Mancuso, R., Del Valle, J., Modol, L., Martinez, A., Granado-Serrano, A. B., Ramirez- Nunez, O., et al. (2014). Resveratrol improves motoneuron function and extends survival in SOD1 ALS mice. Neurotherapeutics 11, 419-432. doi:10.1007/s13311-013-0253-y
55. Martin, L. J., Liu, Z., Chen, K., Price, A. C., Pan, Y., Swaby, J. A., et al. (2007). Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. J. Comp. Neurol. 500, 20-46. doi:10.1002/cne.21160
56. Martinez-Vicente, M., and Cuervo, A. M. (2007). Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol. 6, 352-361. doi:10.1016/S1474-4422(07)70076-5
57. McFarland, K., Spalding, T. A., Hubbard, D., Ma, J. N., Olsson, R., and Burstein, E. S. (2013). Low dose bexarotene treatment rescues dopamine neurons and restores behavioral functions in models of Parkinson’s disease. ACS Chem. Neurosci. 4, 1430-1438. doi:10.1021/cn400100f1
58. Mey, J., and Rombach, N. (1999). Retinoic acid increases BDNF-dependent regeneration of chick retinal ganglion cells in vitro. Neuroreport 10, 3573-3577. doi:10.1097/00001756-199911260-00020
59. Miller, R. G., Mitchell, J. D., and Moore, D. H. (2012). Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database. Syst. Rev. 3, CD001447. doi:10.1002/14651858.CD001447.pub3
60. Moen, P. T. Jr., Johnson, C. V., Byron, M., Shopland, L. S., de la Serna, I. L., Imbalzano, A. N., et al. (2004). Repositioning of muscle-specific genes relative to the periphery of SC-35 domains during skeletal myogenesis. Mol. Biol. Cell 15, 197-206. doi:10.1091/mbc.E03-06-0388
61. Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., et al. (2007). Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10, 615-622. doi:10.1038/nn1876
62. Obulesu, M., Dowlathabad, M. R., and Bramhachari, P. V. (2011). Carotenoids and Alzheimer’s disease: an insight into therapeutic role of retinoids in animal models. Neurochem. Int. 59, 535-541. doi:10.1016/j.neuint.2011.04.004
63. Palanca, A., Casafont, I., Berciano, M. T., and Lafarga, M. (2014). Reactive nucleolar and Cajal body responses to proteasome inhibition in sensory ganglion neurons. Biochim. Biophys. Acta 1842, 848-859. doi:10.1016/j.bbadis.2013.11.016
64. Parakh, S., Spencer, D. M., Halloran, M. A., Soo, K. Y., and Atkin, J. D. (2013). Redox regulation in amyotrophic lateral sclerosis. Oxid. Med. Cell Longev. 2013, 408681. doi:10.1155/2013/408681
65. Pasinelli, P., Belford, M. E., Lennon, N., Bacskai, B. J., Hyman, B. T., Trotti, D., et al. (2004). Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43, 19-30. doi:10.1016/j.neuron.2004.06.021
66. Pasinelli, P., and Brown, R. H. (2006). Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7, 710-723. doi:10.1038/nrn1971
67. Pena, E., Berciano, M. T., Fernandez, R., Ojeda, J. L., and Lafarga, M. (2001). Neuronal body size correlates with the number of nucleoli and Cajal bodies, and with the organization ofthe splicing machinery in rat trigeminal ganglion neurons. J. Comp Neurol. 430, 250­263.
68. doi:10.1002/1096-9861(20010205)430:2<250::AID-CNE1029>3.0.CO;2-L
69. Philips, T., and Robberecht, W. (2011). Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 10, 253-263. doi:10.1016/S1474-4422(11)70015-1
70. Price, A. R., Xu, G., Siemienski, Z. B., Smithson, L. A., Borchelt, D. R., Golde, T. E., et al. (2013). Comment on “ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models”. Science 340, 924d-992d. doi:10.1126/science.1234089
71. Rajawat, Y., Hilioti, Z., and Bossis, I. (2010). Autophagy: a target for retinoic acids.Autophagy 6, 1224-1226. doi:10.4161/auto.6.8.13793
72. Rajawat, Y., Hilioti, Z., and Bossis, I. (2011). Retinoic acid induces autophagosome maturation through redistribution of the cation-independent mannose-6-phos- phate receptor. Antioxid. Redox. Signal. 14, 2165-2177. doi:10.1089/ars.2010.3491
73. Raska, I., Shaw, P. J., and Cmarko, D. (2006). New insights into nucleolar architecture and activity. Int. Rev. Cytol. 255, 177-235. doi:10.1016/S0074-7696(06)55004-1
74. Reichenbach, A., Derouiche, A., and Kirchhoff, F. (2010). Morphology and dynamics of perisynaptic glia. Brain Res. Rev. 63, 11-25. doi:10.1016/j.brainresrev.2010.02.003
75. Riancho, J., Ruiz-Soto, M., Villagra, N. T., Berciano, J., Berciano, M. T., and Lafarga, M. (2014). Compensatory motor neuron response to chromatolysis in the murine hSOD1 G93A model of amyotrophic lateral sclerosis. Front. Cell. Neurosci. 22:346. doi:10.3389/fncel.2014.00346
76. Robberecht, W., and Philips, T. (2013). The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 14, 248-264. doi:10.1038/nrn3430
77. Ross, C. A., and Poirier, M. A. (2004). Protein aggregation and neurodegenerative disease. Nat. Med. 10(Suppl.), S10-S17. doi:10.1038/nm1066
78. Rothstein, J. D. (2009). Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 65(Suppl. 1), S3-S9. doi:10.1002/ana.21543
79. Sato, Y., Meller, R., Yang, T., Taki, W., and Simon, R. P. (2008). Stereo-selective neu­roprotection against stroke with vitamin A derivatives. Brain Res. 1241, 188-192. doi:10.1016/j.brainres.2008.09.020
80. Sau, D., De Biasi, S., Vitellaro-Zuccarello, L., Riso, P., Guarnieri, S., Porrini, M., et al. (2007). Mutation of SOD1 in ALS: a gain of a loss of function. Hum. Mol. Genet. 16, 1604-1618. doi:10.1093/hmg/ddm110
81. Saxena, S., Cabuy, E., and Caroni, P. (2009). A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 12, 627-636. doi:10.1038/nn.2297
82. Schmidt, E. R., Pasterkamp, R. J., and van den Berg, L. H. (2009). Axon guidance pro­teins: novel therapeutic targets for ALS? Prog. Neurobiol. 88, 286-301. doi:10.1016/j.pneurobio.2009.05.004
83. Schrage, K., Koopmans, G., Joosten, E. A., and Mey, J. (2006). Macrophages and neurons are targets of retinoic acid signaling after spinal cord contusion injury. Eur. J. Neurosci. 23, 285-295. doi:10.1111/j.1460-9568.2005.04534.x
84. Shimada, J., Taniguchi, J., Mori, M., Sato, Y., Takuwa, H., Ito, H., et al. (2013). Retinol palmitate prevents ischemia-induced cell changes in hippocampal neurons through the Notch1 signaling pathway in mice. Exp. Neurol. 247, 182-187. doi:10.1016/j.expneurol.2013.04.014
85. Sunico, C. R., Dominguez, G., Garcia-Verdugo, J. M., Osta, R., Montero, F., and Moreno- Lopez, B. (2011). Reduction in the motoneuron inhibitory/excitatory synaptic ratio in an early-symptomatic mouse model of amyotrophic lateral sclerosis. Brain Pathol. 21, 1-15. doi:10.1111/j.1750-3639.2010.00417.x
86. Tan, C. C., Yu, J. T., Tan, M. S., Jiang, T., Zhu, X. C., and Tan, L. (2014). Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy. Neurobiol. Aging 35, 941-957. doi:10.1016/j.neurobiolaging.2013.11.019
87. Tang, Q., Chen, Y., Meyer, C., Geistlinger, T., Lupien, M., Wang, Q., et al. (2011). A comprehensive view of nuclear receptor cancer cistromes. Cancer Res. 71, 6940-6947. doi:10.1158/0008-5472.CAN-11-2091
88. Van Den, B. L., Van Damme, P., Bogaert, E., and Robberecht, W. (2006). The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762, 1068-1082. doi:10.1016/j.bbadis.2006.05.002
89. Vargas, M. R., Burton, N. C., Gan, L., Johnson, D. A., Schafer, M., Werner, S., et al. (2013). Absence of Nrf2 or its selective overexpression in neurons and muscle does not affect survival in ALS-linked mutant hSOD1 mouse models. PLoS One 8:e56625. doi:10.1371/journal.pone.0056625
90. Veeraraghavalu, K., Zhang, C., Miller, S., Hefendehl, J. K., Raj apaksha, T. W., Ulrich, J., et al. (2013). Comment on ‘ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models”. Science 340, 924f-992f. doi:10.1126/science.1235505
91. Vinsant, S., Mansfield, C., Jimenez-Moreno, R., Del, G. M., Yoshikawa, V. M., Hampton, T. G., et al. (2013a). Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part I, background and methods. Brain Behav. 3, 335-350. doi:10.1002/brb3.143
92. Vinsant, S., Mansfield, C., Jimenez-Moreno, R., Del, G. M., Yoshikawa, V. M., Hampton, T. G., et al. (2013b). Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion. Brain Behav. 3, 431-457. doi:10.1002/brb3.142
93. Wakayama, I. (1992). Morphometry of spinal motor neurons in amyotrophic lateral sclerosis with special reference to chromatolysis and intracytoplasmic inclusion bodies. Brain Res. 586, 12-18. doi:10.1016/0006-8993(92)91365-L
94. Wohl, C. A., and Weiss, S. (1998). Retinoic acid enhances neuronal proliferation and astroglial differentiation in cultures of CNS stem cell-derived precursors. J. Neurobiol. 37, 281-290. doi:10.1002/(SICI)1097-4695(19981105)37:2<281::AID-NEU7> 3.0.CO;2-J
95. Wootz, H., Weber, E., Korhonen, L., and Lindholm, D. (2006). Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival. Neuroscience 143, 419-430. doi:10.1016/j.neuroscience.2006.07.048
96. Xing, Y., Johnson, C. V., Dobner, P. R., and Lawrence, J. B. (1993). Higher level organi­zation of individual gene transcription and RNA splicing. Science 259, 1326-1330. doi:10.1126/science.8446901
97. Yamanaka, K., Boillee, S., Roberts, E. A., Garcia, M. L., McAlonis-Downes, M., Mikse, O. R., et al. (2008). Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc. Natl. Acad. Sci. U.S.A. 105, 7594-7599. doi:10.1073/pnas.0802556105
98. Zang, D. W., Lopes, E. C., and Cheema, S. S. (2005). Loss of synaptophysin-positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS. J. Neurosci. Res. 79, 694-699. doi:10.1002/jnr.20379